Vikas Sinha

CIK 1337845 · Chief Financial Officer · last filed 2026-04-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.39M

Companies

3

Total Filings

128

Lifetime Open-Market Net

-$4.66M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Chief Financial Officer 619,856 $44.18 $27.39M -$1.23M 5 2026-04-20
Verona Pharma plc (VRNA) Delisted Director 0 $106.91 $0 -$3.18M 12 2025-10-08
Kalaris Therapeutics, Inc. (ALVR) Delisted See Remarks 774,118 $9.81 $7.59M -$246.5K 40 2025-02-24

Recent Filings · Page 10 of 13

128 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-07-27 Mixed −871 -$1.39M
2011-07-15 Mixed -$664.6K
2011-07-12 Sell (S) −977 -$48.9K
2011-06-01 Mixed +4,504 $53.7K
2011-04-04 Mixed -$862.1K
2011-02-16 Mixed +5,002 -$1.42M
2011-02-04 Grant (A) +7,000 $0
2011-01-28 Sell (S) −1,731 -$146.6K
2011-01-18 Sell (S) −540 -$44.6K
2011-01-12 Sell (S) −532 -$43.2K
Showing 91100 of 128
Page 10 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.